Institutional investors purchased a net $60.6 million shares of ABT during the quarter ended March 2017 and now own 74.22% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 21.5 Million shares of Abbott Laboratories
WELLINGTON MANAGEMENT CO. LLP Bought 11.2 Million shares of Abbott Laboratories
THE VANGUARD GROUP, INC. Bought 8.7 Million shares of Abbott Laboratories